Drug Manufacturers - Specialty & Generic | Healthcare
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
Market Cap
40584015872
Current Price
372.45
52 Week Range
208.0 - 377.5
Previous Close
362.25
Open
364.9
Sector
Healthcare
Address
Themis House, 11/12 Udyog Nagar S.V Road Goregaon (West), Mumbai, 400104, India
Phone
+91-22676-07080
Fax
+91-22676-07019
Website
https://www.gtbl.in
Day Low
353.75
Day High
377.5
Dividend Yield
PE Ratio
82.95101
Earnings Per Share
4.49
Beta
-0.507
EBITDA
691219008
Book Value
22.795
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Bhavik Shah | Chief Financial Officer | - | - |
Mr. Do-Seon Kim | Chief Technical Officer | - | - |
Mr. Vineet G. Gawankar | Company Secretary & Compliance Officer | - | - |
Mr. Rajneesh Kedarnath Anand | Senior Executive | 70 | 1954 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.